These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30071306)

  • 1. Variation of bone acquisition during growth hormone treatment in children can be explained by proteomic biomarkers, bone formation markers, body composition and nutritional factors.
    Swolin-Eide D; Andersson B; Hellgren G; Magnusson P; Albertsson-Wikland K
    Bone; 2018 Nov; 116():144-153. PubMed ID: 30071306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment.
    Boot AM; Nauta J; de Jong MC; Groothoff JW; Lilien MR; van Wijk JA; Kist-van Holthe JE; Hokken-Koelega AC; Pols HA; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):665-72. PubMed ID: 10197084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term changes in bone formation markers following growth hormone (GH) treatment in short prepubertal children with a broad range of GH secretion.
    Andersson B; Swolin-Eide D; Magnusson P; Albertsson-Wikland K
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):91-9. PubMed ID: 24818653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein markers predict body composition during growth hormone treatment in short prepubertal children.
    Decker R; Andersson B; Nierop AF; Bosaeus I; Dahlgren J; Albertsson-Wikland K; Hellgren G
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):675-82. PubMed ID: 23469944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ; van der Kaay DC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of growth hormone treatment on bone mineral density and body composition in girls with turner syndrome.
    Ari M; Bakalov VK; Hill S; Bondy CA
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4302-5. PubMed ID: 16940444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of orlistat on bone turnover and body composition.
    Gotfredsen A; Westergren Hendel H; Andersen T
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1154-60. PubMed ID: 11486790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone density and body composition in chronic renal failure: effects of growth hormone treatment.
    van der Sluis IM; Boot AM; Nauta J; Hop WC; de Jong MC; Lilien MR; Groothoff JW; van Wijk AE; Pols HA; Hokken-Koelega AC; de Muinck Keizer-Schrama SM
    Pediatr Nephrol; 2000 Dec; 15(3-4):221-8. PubMed ID: 11149115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities.
    Matsuoka H; Fors H; Bosaeus I; Rosberg S; Albertsson-Wikland K; Bjarnason R
    Eur J Endocrinol; 1999 Jan; 140(1):35-42. PubMed ID: 10037249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone treatment of osteoporotic postmenopausal women - a one-year placebo-controlled study.
    Sääf M; Hilding A; Thorën M; Troell S; Hall K
    Eur J Endocrinol; 1999 May; 140(5):390-9. PubMed ID: 10229902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.
    Boot AM; Engels MA; Boerma GJ; Krenning EP; De Muinck Keizer-Schrama SM
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2423-8. PubMed ID: 9253311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone improves bone mineral content in children with cystic fibrosis.
    Hardin DS; Ahn C; Prestidge C; Seilheimer DK; Ellis KJ
    J Pediatr Endocrinol Metab; 2005 Jun; 18(6):589-95. PubMed ID: 16042327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of body composition and bone in patients with juvenile idiopathic arthritis treated with growth hormone.
    Bechtold S; Ripperger P; Dalla Pozza R; Roth J; Häfner R; Michels H; Schwarz HP
    J Clin Endocrinol Metab; 2010 Jan; 95(1):178-85. PubMed ID: 19880788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children.
    Crofton PM; Stirling HF; Schönau E; Kelnar CJ
    Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.